A review of stem cell translation and potential confounds by cancer stem cells

Stem Cells International

Volumn , Issue , 2013, Pages

  Bibber, Bernadette ^a,b   Sinha, Garima ^a,b   Lobba, Aline R M ^c   Greco, Steven J ^b   Rameshwar, Pranela ^b  

^a Graduate School of Biomedical Sciences   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893678593     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2013/241048     Document Type: Review

References (89)

1. Chabannon C., Pamphilon D., Vermylen C., Gratwohl A., Niederwieser D., McGrath E., Lamers C., Lanza F., Slaper-Cortenbach I., Madrigal A., Apperley J., Ten years after the first inspection of a candidate European centre, an EBMT registry analysis suggests that clinical outcome is improved when hematopoietic SCT is performed in a JACIE accredited program. Bone Marrow Transplantation 2012 47 1 15 17 2-s2.0-84855747786 10.1038/bmt.2011.32
2. Wujcik D. M., As we look back at the history of BMT, we also look forward to the future of ONS Connect. ONS Connect 2012 27 11, article 7
3. Mundra V., Gerling I. C., Mahato R. I., Mesenchymal stem cell-based therapy. Molecular Pharmaceutics 2013 10 1 77 89 10.1021/mp3005148
4. Peng X., Liu T., Wang Y., Yan Q., Jin H., Li L., Qian Q., Wu M., Wnt/beta-catenin signaling in embryonic stem cell converted tumor cells. Journal of Translational Medicine 2012 10 article 196 10.1186/1479-5876-10-196
5. Hare J. M., Fishman J. E., Gerstenblith: G., Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the poseidon randomized trial. Journal of the American Medical Association 2012 308 22 2369 2379 10.1001/jama.2012.25321
6. Chen F. M., Wu L. A., Zhang M., Zhang R., Sun H. H., Homing of endogenous stem/progenitor cells for in situ tissue regeneration: promises, strategies, and translational perspectives. Biomaterials 2011 32 12 3189 3209 2-s2.0-79951740978 10.1016/j.biomaterials.2010.12.032
7. Campagnoli C., Roberts I. A. G., Kumar S., Bennett P. R., Bellantuono I., Fisk N. M., Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 2001 98 8 2396 2402 2-s2.0-0035889146 10.1182/blood.V98.8.2396
8. He Q., Wan C., Li G., Concise review: multipotent mesenchymal stromal cells in blood. Stem Cells 2007 25 1 69 77 2-s2.0-33845983611 10.1634/stemcells.2006-0335
9. Lee O. K., Kuo T. K., Chen W. M., Lee K. D., Hsieh S. L., Chen T. H., Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004 103 5 1669 1675 2-s2.0-1442356953 10.1182/blood-2003-05-1670
10. Romanov Y. A., Svintsitskaya V. A., Smirnov V. N., Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells 2003 21 1 105 110 2-s2.0-0037240649
11. Tsuda H., Yamahara K., Ishikane S., Otani K., Nakamura A., Sawai K., Ichimaru N., Sada M., Taguchi A., Hosoda H., Tsuji M., Kawachi H., Horio M., Isaka Y., Kangawa K., Takahara S., Ikeda T., Allogenic fetal membrane-derived mesenchymal stem cells contribute to renal repair in experimental glomerulonephritis. American Journal of Physiology-Renal Physiology 2010 299 5 F1004 F1013 2-s2.0-78349290728 10.1152/ajprenal.00587.2009
12. Thomson J. A., Embryonic stem cell lines derived from human blastocysts. Science 1998 282 5391 1145 1147 2-s2.0-0032491416
13. Gutierrez-Aranda I., Ramos-Mejia V., Bueno C., Munoz-Lopez M., Real P. J., Mácia A., Sanchez L., Ligero G., Garcia-Parez J. L., Menendez P., Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection. Stem Cells 2010 28 9 1568 1570 2-s2.0-77958133875 10.1002/stem.471
14. Anjos-Afonso F., Bonnet D., Nonhematopoietic/endothelial SSEA-1+ cells define the most primitive progenitors in the adult murine bone marrow mesenchymal compartment. Blood 2007 109 3 1298 1306 2-s2.0-33846866732 10.1182/blood-2006-06-030551
15. Gang E. J., Bosnakovski D., Figueiredo C. A., Visser J. W., Perlingeiro R. C. R., SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood 2007 109 4 1743 1751 2-s2.0-33846918135 10.1182/blood-2005-11-010504
16. Bonfield T. L., Caplan A. I., Adult mesenchymal stem cells: an innovative therapeutic for lung diseases. Discovery medicine 2010 9 47 337 345 2-s2.0-77956622280
17. Tang Q. Q., Otto T. C., Lane M. D., Commitment of C3H10T1/2 pluripotent stem cells to the adipocyte lineage. Proceedings of the National Academy of Sciences of the United States of America 2004 101 26 9607 9611 2-s2.0-3042759742 10.1073/pnas.0403100101
18. Zhang X., Schwarz E. M., Young D. A., Edward Puzas J., Rosier R. N., O'Keefe R. J., Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. Journal of Clinical Investigation 2002 109 11 1405 1415 2-s2.0-0036259278 10.1172/JCI200215681
19. Yagi H., Soto-Gutierrez A., Parekkadan B., Kitagawa Y., Tompkins R. G., Kobayashi N., Yarmush M. L., Mesenchymal stem cells: mechanisms of immunomodulation and homing. Cell Transplantation 2010 19 6-7 667 679 2-s2.0-77958572322 10.3727/096368910X508762
20. Bianco P., Riminucci M., Gronthos S., Robey P. G., Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 2001 19 3 180 192 2-s2.0-0034988303
21. Rameshwar P., IFN γ and B7-H1 in the immunology of mesenchymal stem cells. Cell Research 2008 18 8 805 806 2-s2.0-49149125175 10.1038/cr.2008.90
22. Patel S. A., Sherman L., Munoz J., Rameshwar P., Immunological properties of mesenchymal stem cells and clinical implications. Archivum Immunologiae et Therapiae Experimentalis 2008 56 1 1 8 2-s2.0-43049180078 10.1007/s00005-008- 0001-x
23. Chan J. L., Tang K. C., Patel A. P., Bonilla L. M., Pierobon N., Ponzio N. M., Rameshwar P., Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon- γ Blood 2006 107 12 4817 4824 2-s2.0-33745076513 10.1182/blood-2006-01-0057
24. Sheng H., Wang Y., Jin Y., Zhang Q., Zhang Y., Wang L., Shen B., Yin S., Liu W., Cui L., Li N., A critical role of IFN γ in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1. Cell Research 2008 18 8 846 857 2-s2.0-49149120713 10.1038/cr.2008.80
25. Bartholomew A., Sturgeon C., Siatskas M., Ferrer K., McIntosh K., Patil S., Hardy W., Devine S., Ucker D., Deans R., Moseley A., Hoffman R., Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Experimental Hematology 2002 30 1 42 48 2-s2.0-0036142769 10.1016/S0301-472X(01)00769-X
26. Jiang X. X., Zhang Y., Liu B., Zhang S. X., Wu Y., Yu X. D., Mao N., Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 2005 105 10 4120 4126 2-s2.0-18544371666 10.1182/blood-2004-02-0586
27. Nauta A. J., Kruisselbrink A. B., Lurvink E., Willemze R., Fibbe W. E., Mesenchymal stem cells inhibit generation and function of both CD34 +-derived and monocyte-derived dendritic cells. Journal of Immunology 2006 177 4 2080 2087 2-s2.0-33746898242
28. Patel S. A., Meyer J. R., Greco S. J., Corcoran K. E., Bryan M., Rameshwar P., Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF- β Journal of Immunology 2010 184 10 5885 5894 2-s2.0-77954728855 10.4049/jimmunol.0903143
29. Jonuleit H., Schmitt E., The regulator T cell family: distinct subsets and their interrelations. Journal of Immunology 2003 171 12 6323 6327 2-s2.0-0346996879
30. Suri-Payer E., Amar A. Z., Thornton A. M., Shevach E. M., CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. Journal of Immunology 1998 160 3 1212 1218 2-s2.0-0031939403
31. Schena F., Gambini C., Gregorio A., Mosconi M., Reverberi D., Gattorno M., Casazza S., Uccelli A., Moretta L., Martini A., Traggiai E., Interferon- γ -dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus. Arthritis and Rheumatism 2010 62 9 2776 2786 2-s2.0-77956371047 10.1002/art.27560
32. Corcione A., Benvenuto F., Ferretti E., Giunti D., Cappiello V., Cazzanti F., Risso M., Gualandi F., Mancardi G. L., Pistoia V., Uccelli A., Human mesenchymal stem cells modulate B-cell functions. Blood 2006 107 1 367 372 2-s2.0-30144440925 10.1182/blood-2005-07-2657
33. Pevsner-Fischer M., Morad V., Cohen-Sfady M., Rousso-Noori L., Zanin-Zhorov A., Cohen S., Cohen I. R., Zipori D., Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood 2007 109 4 1422 1432 2-s2.0-33846914143 10.1182/blood-2006-06-028704
34. Liotta F., Angeli R., Cosmi L., Filì L., Manuelli C., Frosali F., Mazzinghi B., Maggi L., Pasini A., Lisi V., Santarlasci V., Consoloni L., Angelotti M. L., Romagnani P., Parronchi P., Krampera M., Maggi E., Romagnani S., Annunziato F., Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing notch signaling. Stem Cells 2008 26 1 279 289 2-s2.0-38349060182 10.1634/stemcells.2007-0454
35. Nagai Y., Garrett K. P., Ohta S., Bahrun U., Kouro T., Akira S., Takatsu K., Kincade P. W., Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity 2006 24 6 801 812 2-s2.0-33744978765 10.1016/j.immuni.2006.04.008
36. Ren G., Chen X., Dong F., Li W., Ren X., Zhang Y., Shi Y., Concise review: mesenchymal stem cells and translational medicine: emerging issues. Stem Cells Translational Medicine 2012 1 1 51 58 10.5966/sctm.2011-0019
37. Cheng H., Kastrup C. J., Ramanathan R., Siegwart D. J., Ma M., Bogatyrev S. R., Xu Q., Whitehead K. A., Langer R., Anderson D. G., Nanoparticulate cellular patches for cell-mediated tumoritropic delivery. ACS Nano 2010 4 2 625 631 2-s2.0-77649170226 10.1021/nn901319y
38. Roger M., Clavreul A., Venier-Julienne M. C., Passirani C., Sindji L., Schiller P., Montero-Menei C., Menei P., Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors. Biomaterials 2010 31 32 8393 8401 2-s2.0-77956182174 10.1016/j.biomaterials.2010.07.048
39. Constantin G., Marconi S., Rossi B., Angiari S., Calderan L., Anghileri E., Gini B., Bach S. D., Martinello M., Bifari F., Galiè M., Turano E., Budui S., Sbarbati A., Krampera M., Bonetti B., Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Stem Cells 2009 27 10 2624 2635 2-s2.0-70350212973 10.1002/stem.194
40. Hofstetter C. P., Schwarz E. J., Hess D., Widenfalk J., El Manira A., Prockop D. J., Olson L., Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proceedings of the National Academy of Sciences of the United States of America 2002 99 4 2199 2204 2-s2.0-0037133174 10.1073/pnas.042678299
41. Kitaori T., Ito H., Schwarz E. M., Tsutsumi R., Yoshitomi H., Oishi S., Nakano M., Fujii N., Nagasawa T., Nakamura T., Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Arthritis and Rheumatism 2009 60 3 813 823 2-s2.0-61649090805 10.1002/art.24330
42. Marinova-Mutafchieva L., Taylor P., Funa K., Maini R. N., Zvaifler N. J., Mesenchymal cells expressing bone morphogenetic protein receptors are present in the rheumatoid arthritis joint. Arthritis & Rheumatism 2000 43 2046 2055
43. Quarto R., Mastrogiacomo M., Cancedda R., Kutepov S. M., Mukhachev V., Lavroukov A., Kon E., Marcacci M., Repair of large bone defects with the use of autologous bone marrow stromal cells. New England Journal of Medicine 2001 344 5 385 386 2-s2.0-0035253558 10.1056/NEJM200102013440516
44. Rao G., Patel P. S., Idler S. P., Maloof P., Gascon P., Potian J. A., Rameshwar P., Facilitating role of preprotachykinin-I dene in the integration of breast cancer cells within the stromal compartment of the bone marrow: a model of early cancer progression. Cancer Research 2004 64 8 2874 2881 2-s2.0-4344718326 10.1158/0008-5472.CAN-03-3121
45. Ge X., Bai C., Yang J., Lou G., Li Q., Chen R., Intratracheal transplantation of bone marrow-derived mesenchymal stem cells reduced airway inflammation and up-regulated CD4(+)CD25(+) regulatory T cells in asthmatic mouse. Cell Biol Int 2013 37 7 675 686 10.1002/cbin.10084
46. Min C. K., Kim B. G., Park G., Cho B., Oh I. H., IL-10-transduced bone marrow mesenchymal stem cells can attenuate the severity of acute graft-versus-host disease after experimental allogeneic stem cell transplantation. Bone Marrow Transplantation 2007 39 10 637 645 2-s2.0-34248213189 10.1038/sj.bmt.1705644
47. Collins F. S., Haseltine W. A., Of genes and genomes: what lies between the base pairs. Journal of Investigative Medicine 2000 48 5 295 301 2-s2.0-0033865847
48. He J. Q., Ma Y., Lee Y., Thomson J. A., Kamp T. J., Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circulation Research 2003 93 1 32 39 2-s2.0-0038300672 10.1161/01.RES.0000080317.92718.99
49. Björklund L. M., Sánchez-Pernaute R., Chung S., Andersson T., Chen I. Y. C., McNaught K. S. P., Brownell A. L., Jenkins B. G., Wahlestedt C., Kim K. S., Isacson O., Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proceedings of the National Academy of Sciences of the United States of America 2002 99 4 2344 2349 2-s2.0-0037133163 10.1073/pnas.022438099
50. Suzuki A., Raya Á., Kawakami Y., Morita M., Matsui T., Nakashima K., Gage F. H., Rodríguez-Esteban C., Izpiśa Belmonte J. C., Maintenance of embryonic stem cell pluripotency by Nanog-mediated reversal of mesoderm specification. Nature Clinical Practice Cardiovascular Medicine 2006 3 1 S114 S122 2-s2.0-33644632992 10.1038/ncpcardio0442
51. Hymes S. R., Alousi A. M., Cowen E. W., Graft-versus-host disease. Part II: management of cutaneous graft-versus-host disease. Journal of the American Academy of Dermatology 2012 66 4 535.e1 535.e16 2-s2.0-84858302314 10.1016/j.jaad.2011.11.961
52. Papewalis C., Topolar D., Gotz B., Schonberger S., Dilloo: D., Mesenchymal stem cells as cellular immunotherapeutics in allogeneic hematopoietic stem cell transplantation. Advances in Biochemical Engineering/Biotechnology 2013 10.1007/10-2012-158
53. Boyle A. J., Schulman S. P., Hare J. M., Stem cell therapy for cardiac repair: ready for the next step. Circulation 2006 114 4 339 352 2-s2.0-33748069125 10.1161/CIRCULATIONAHA.105.590653
54. Assmus B., Schächinger V., Teupe C., Britten M., Lehmann R., Döbert N., Grünwald F., Aicher A., Urbich C., Martin H., Hoelzer D., Dimmeler S., Zeiher A. M., Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002 106 24 3009 3017 2-s2.0-0037058848 10.1161/01.CIR.0000043246.74879.CD
55. Schächinger V., Assmus B., Britten M. B., Honold J., Lehmann R., Teupe C., Abolmaali N. D., Vogl T. J., Hofmann W. K., Martin H., Dimmeler S., Zeiher A. M., Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI trial. Journal of the American College of Cardiology 2004 44 8 1690 1699 2-s2.0-5644236574 10.1016/j.jacc.2004.08.014
56. Wollert K. C., Meyer G. P., Lotz J., Ringes-Lichtenberg S., Lippolt P., Breidenbach C., Fichtner S., Korte T., Hornig B., Messinger D., Arseniev L., Hertenstein B., Ganser A., Drexler H., Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004 364 9429 141 148 2-s2.0-3042710733 10.1016/S0140-6736(04) 16626-9
57. Caplan A. I., Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. Journal of Cellular Physiology 2007 213 2 341 347 2-s2.0-34848863384 10.1002/jcp.21200
58. Lim P. K., Bliss S. A., Patel S. A., Taborga M., Dave M. A., Gregory L. A., Greco S. J., Bryan M., Patel P. S., Rameshwar P., Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. Cancer Research 2011 71 5 1550 1560 2-s2.0-79952219931 10.1158/0008-5472.CAN-10-2372
59. Min J. Y., Sullivan M. F., Yang Y., Zhang J. P., Converso K. L., Morgan J. P., Xiao Y. F., Significant improvement of heart function by cotransplantation of human mesenchymal stem cells and fetal cardiomyocytes in postinfarcted pigs. Annals of Thoracic Surgery 2002 74 5 1568 1575 2-s2.0-0036840523 10.1016/S0003-4975(02)03952-8
60. Delude C., Tumorigenesis: testing ground for cancer stem cells. Nature 2011 480 7377 S43 S45 2-s2.0-83455238249 10.1038/480S43a
61. Greaves M., Maley C. C., Clonal evolution in cancer. Nature 2012 481 7381 306 313 2-s2.0-84856013431 10.1038/nature10762
62. Patel S. A., Ramkissoon S. H., Bryan M., Pliner L. F., Dontu G., Patel P. S., Amiri S., Pine S. R., Rameshwar P., Delineation of breast cancer cell hierarchy identifies the subset responsible for dormancy. Scientific Reports 2012 2 article 906 10.1038/srep00906
63. Goldstein R. H., Reagan M. R., Anderson K., Kaplan D. L., Rosenblatt M., Human bone marrow-derived mscs can home to orthotopic breast cancer tumors and promote bone metastasis. Cancer Research 2010 70 24 10044 10050 2-s2.0-78650337010 10.1158/0008-5472.CAN-10-1254
64. Reddy B. Y., Lim P. K., Silverio K., Patel S. A., Won B. W., Rameshwar P., The microenvironmental effect in the progression, metastasis, and dormancy of breast cancer: a model system within bone marrow. International Journal of Breast Cancer 2012 2012 7 721659 10.1155/2012/721659
65. Karnoub A. E., Dash A. B., Vo A. P., Sullivan A., Brooks M. W., Bell G. W., Richardson A. L., Polyak K., Tubo R., Weinberg R. A., Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007 449 7162 557 563 2-s2.0-34948896045 10.1038/nature06188
66. Chaturvedi P., Gilkes D. M., Wong C. C. L., Kshitiz, Luo W., Zhang H., Wei H., Takano N., Schito L., Levchenko A., Semenza G. L., Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis. Journal of Clinical Investigation 2013 123 1 189 205 10.1172/JCI64993
67. Yan X. L., Fu C. J., Chen L., Qin J. H., Zeng Q., Yuan H. F., Nan X., Chen H. X., Zhou J. N., Lin Y. L., Zhang X. M., Yu C. Z., Yue W., Pei X. T., Mesenchymal stem cells from primary breast cancer tissue promote cancer proliferation and enhance mammosphere formation partially via EGF/EGFR/Akt pathway. Breast Cancer Research and Treatment 2012 132 1 153 164 2-s2.0-84857915804 10.1007/s10549-011-1577-0
68. Bergfeld S. A., DeClerck Y. A., Bone marrow-derived mesenchymal stem cells and the tumor microenvironment. Cancer and Metastasis Reviews 2010 29 2 249 261 2-s2.0-77954564230 10.1007/s10555-010-9222-7
69. Reagan M. R., Kaplan D. L., Concise review: mesenchymal stem cell tumor-homing: detection methods in disease model systems. Stem Cells 2011 29 6 920 927 2-s2.0-79957617918 10.1002/stem.645
70. Torsvik A., Bjerkvig R., Mesenchymal stem cell signaling in cancer progression. Cancer Treatment Reviews 2013 39 2 180 188 2-s2.0-84859404856 10.1016/j.ctrv.2012.03.005
71. Habeck M., Bone-marrow analysis predicts breast-cancer recurrence. Molecular Medicine Today 2000 6 7 256 257 2-s2.0-0033919994 10.1016/S1357- 4310(00)01733-0
72. Mansi J. L., Berger U., McDonnell T., Pople A., Rayter Z., Gazet J. C., Coombes R. C., The fate of bone marrow micrometastases in patients with primary breast cancer. Journal of Clinical Oncology 1989 7 4 445 449 2-s2.0-0024584328
73. Naume B., Zhao X., Synnestvedt M., Borgen E., Russnes H. G., Lingjærde O. C., Strømberg M., Wiedswang G., Kvalheim G., Kåresen R., Nesland J. M., Børresen-Dale A. L., Sørlie T., Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer. Molecular Oncology 2007 1 2 2 160 171 2-s2.0-77949309853 10.1016/j.molonc.2007.03.004
74. Riethdorf S., Wikman H., Pantel K., Review: biological relevance of disseminated tumor cells in cancer patients. International Journal of Cancer 2008 123 9 1991 2006 2-s2.0-51649120140 10.1002/ijc.23825
75. Klein C. A., Framework models of tumor dormancy from patient-derived observations. Current Opinion in Genetics and Development 2011 21 1 42 49 2-s2.0-79551643707 10.1016/j.gde.2010.10.011
76. Aguirre-Ghiso J. A., Bragado P., Sosa M. S., Metastasis awakening: targeting dormant cancer. Nature Medicine 2013 19 276 277 10.1038/nm.3120
77. Yamaguchi T., Wing J. B., Sakaguchi S., Two modes of immune suppression by Foxp3+ regulatory T cells under inflammatory or non-inflammatory conditions. Seminars in Immunology 2011 23 6 424 430 2-s2.0-82755184094 10.1016/j.smim.2011. 10.002
78. Corcoran K. E., Trzaska K. A., Fernandes H., Bryan M., Taborga M., Srinivas V., Packman K., Patel P. S., Rameshwar P., Mesenchymal stem cells in early entry of breast cancer into bone marrow. PLoS ONE 2008 3 6 2-s2.0-49649110387 10.1371/journal.pone.0002563 e2563
79. Greco S. J., Patel S. A., Bryan M., Pliner L. F., Banerjee D., Rameshwar P., AMD3100-mediated production of interleukin-1 from mesenchymal stem cells is key to chemosensitivity of breast cancer cells. American Journal of Cancer Research 2011 1 6 701 715
80. Comşa Ş., Ciuculescu F., Raica M., Mesenchymal stem cell-tumor cell cooperation in breast cancer vasculogenesis. Molecular Medicine Reports 2012 5 5 1175 1180 2-s2.0-84858199250 10.3892/mmr.2012.796
81. Momin E. N., Vela G., Zaidi H. A., Quiñones-Hinojosa A., The oncogenic potential of mesenchymal stem cells in the treatment of cancer: directions for future research. Current Immunology Reviews 2010 6 2 137 148 2-s2.0-77952523353 10.2174/157339510791111718
82. Feng B., Chen L., Review of mesenchymal stem cells and tumors: executioner or coconspirator? Cancer Biotherapy and Radiopharmaceuticals 2009 24 6 717 721 2-s2.0-73649091784 10.1089/cbr.2009.0652
83. Rameshwar P., Breast cancer cell dormancy in bone marrow: potential therapeutic targets within the marrow microenvironment. Expert Review of Anticancer Therapy 2010 10 2 129 132 2-s2.0-76749124016 10.1586/ERA.10.3
84. Greco S. J., Rameshwar P., Microenvironmental considerations in the application of human mesenchymal stem cells in regenerative therapies. Biologics: Targets and Therapy 2008 2 4 699 705 2-s2.0-77949359783
85. Riggi N., Suvà M. L., de Vito C., Provero P., Stehle J. C., Baumer K., Cironi L., Janiszewska M., Petricevic T., Suvà D., Tercier S., Joseph J. M., Guillou L., Stamenkovic I., EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells. Genes and Development 2010 24 9 916 932 2-s2.0-77951785861 10.1101/gad.1899710
86. de Boeck A., Narine K., de Neve W., Mareel M., Bracke M., de Wever O., Resident and bone marrow-derived mesenchymal stem cells in head and neck squamous cell carcinoma. Oral Oncology 2010 46 5 336 342 2-s2.0-77950957772 10.1016/j.oraloncology.2010.01.016
87. Mishra P. J., Mishra P. J., Humeniuk R., Medina D. J., Alexe G., Mesirov J. P., Ganesan S., Glod J. W., Banerjee D., Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Research 2008 68 11 4331 4339 2-s2.0-49249120549 10.1158/0008-5472.CAN-08-0943
88. Badve S., Nakshatri H., Breast-cancer stem cells-beyond semantics. The Lancet Oncology 2012 13 1 e43 e48 10.1016/S1470-2045(11)70191-7
89. Liu X., Duan B., Cheng Z., Jia X., Mao L., Fu H., Che Y., Ou L., Liu L., Kong D., SDF-1/CXCR4 axis modulates bone marrow mesenchymal stem cell apoptosis, migration and cytokine secretion. Protein and Cell 2011 2 10 845 854 2-s2.0-80955157950 10.1007/s13238-011-1097-z